Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteinuria, hyperlipidemia, and the kidney

F N Hutchison1

  • 1Division of Nephrology, Medical University of South Carolina, Charleston.

Mineral and Electrolyte Metabolism
|January 1, 1993
PubMed
Summary

Nephrotic syndrome causes hyperlipidemia due to lipid metabolism issues. Treating hyperlipidemia and proteinuria can protect kidneys from injury.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resistance to remnant nephropathy in the Wistar-Furth rat.

Journal of the American Society of Nephrology : JASN·1999
Same author

High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms.

Mineral and electrolyte metabolism·1998
Same author

Effect of dietary protein and enalapril on proximal tubular delivery and absorption of albumin in nephrotic rats.

The American journal of physiology·1996
Same author

Differential effects of diabetes and glomerulonephritis on glomerular basement membrane composition.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·1996
Same author

The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin.

Journal of the American Society of Nephrology : JASN·1995
Same author

Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.

Kidney international·1995

Area of Science:

  • Nephrology
  • Lipid Metabolism
  • Renal Disease

Background:

  • Hyperlipidemia is common in nephrotic syndrome, stemming from abnormal lipid synthesis and breakdown.
  • The exact cause of nephrotic hyperlipidemia is unknown, but impaired glomerular filtration and low oncotic pressure may play roles.

Purpose of the Study:

  • To explore the relationship between hyperlipidemia and nephrotic syndrome.
  • To investigate the impact of hyperlipidemia on kidney injury and proteinuria.
  • To evaluate therapeutic strategies for nephrotic hyperlipidemia.

Main Methods:

  • Analysis of lipid and lipoprotein metabolism in nephrotic patients.
  • Review of existing literature on hyperlipidemia and kidney disease.
  • Examination of animal models to understand mechanisms of renal injury.

Main Results:

  • Abnormal lipid metabolism (synthesis and catabolism) characterizes nephrotic hyperlipidemia.
  • Reduced serum oncotic pressure and abnormal glomerular permeability contribute to hyperlipidemia.
  • Standard lipid-lowering drugs, dietary protein restriction, and ACE inhibitors show efficacy.
  • Hyperlipidemia can independently cause kidney damage and worsen existing renal disease in animal models.
  • Hyperlipidemia treatment mitigates renal injury and reduces proteinuria.

Conclusions:

  • Hyperlipidemia is a significant factor in nephrotic syndrome, linked to lipid metabolism disturbances.
  • Therapies targeting proteinuria and improving oncotic pressure, alongside lipid management, are beneficial.
  • Hyperlipidemia can directly cause or exacerbate kidney injury through inflammatory and paracrine mechanisms.

Related Experiment Videos